ReviewFrontiers in aging2025
Advanced immunology in aging population: unveiling the complexities of vaccine responsiveness.
Review in Frontiers in aging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- AI-driven big data analysis and predictive modeling of infectious disease immunity: from correlates to causal, multiscale understanding.Archives of microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
With the accelerating global population aging, vaccine responsiveness in older adults has emerged as an increasingly critical issue. This review systematically explores age-related changes in immune system function and their impacts on vaccine efficacy. Firstly, we outline the characteristics of immunosenescence and its regulatory effects on vaccine effectiveness from three perspectives: cellular, molecular, and signaling pathway levels. Secondly, we summarize methods for predicting vaccine immune responsiveness (such as biomarkers and advanced immunological assays) and current mainstream strategies for enhancing vaccine immune responsiveness, while enumerating several prominent novel vaccine formulations targeting the older adult population. Finally, we discuss existing controversies and future research directions regarding the study of vaccine responsiveness in older adults, and comprehensively evaluate the current research status of vaccine responsiveness in this demographic. By synthesizing extensive evidence, this review aims to provide new insights into addressing the challenges of vaccinating the older adult population and lay a theoretical foundation for developing more effective immunization strategies tailored to this vulnerable group.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.